adMare Bioinnovations Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
68
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$92M
- Investors
-
1
adMare Bioinnovations General Information
Description
Operator of a life sciences innovation hub intended to build companies, ecosystems, and industry-ready talent. The company's services include sourcing therapeutically promising research from academic and biotech partners to create new companies, providing specialized expertise, infrastructure, and capital to help existing companies scale up, and driving the growth of those companies by training qualified personnel, enabling biotechnology startups to further develop their product pipelines and advance their business to the next inflection point.
Contact Information
Website
www.admarebio.comCorporate Office
- UBC Innovation Centre
- 2405 Wesbrook Mall, 4th Floor
- Vancouver, British Columbia V6T 1Z3
- Canada
Corporate Office
- UBC Innovation Centre
- 2405 Wesbrook Mall, 4th Floor
- Vancouver, British Columbia V6T 1Z3
- Canada
adMare Bioinnovations Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Grant | 30-Mar-2022 | $92M | Completed | Generating Revenue | ||
| 1. Merger of Equals | 30-May-2019 | Completed | Generating Revenue |
adMare Bioinnovations Patents
adMare Bioinnovations Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2020207426-A1 | Crystalline forms of (s)-2-(7-cyano-1h-benzimidazol-1 yl)- n-{1-(4-(1-cyano-1-methylethyl)phenyl)ethyl}acetamide | Inactive | 08-Jan-2019 | ||
| CA-3125655-A1 | Crystalline forms of (s)-2-(7-cyano-1h-benzimidazol-1 yl)- n-{1-[4-(1-cyano-1-methylethyl)phenyl]ethyl}acetamide | Pending | 08-Jan-2019 | ||
| EP-3908574-A1 | Crystalline forms of (s)-2-(7-cyano-1h-benzimidazol-1 yl)- n-{1-[4-(1-cyano-1-methylethyl)phenyl]ethyl}acetamide | Inactive | 08-Jan-2019 | ||
| EP-3908574-A4 | Crystalline forms of (s)-2-(7-cyano-1h-benzimidazol-1 yl)- n-{1-[4-(1-cyano-1-methylethyl)phenyl]ethyl}acetamide | Inactive | 08-Jan-2019 | ||
| WO-2020142842-A1 | Crystalline forms of (s)-2-(7-cyano-1h-benzimidazol-1 yl)- n-{1-[4-(1-cyano-1-methylethyl)phenyl]ethyl}acetamide | Inactive | 08-Jan-2019 | C07D235/16 |
adMare Bioinnovations Signals
adMare Bioinnovations Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Government of Canada | Limited Partner |
adMare Bioinnovations Investments & Acquisitions (34)
adMare Bioinnovations’s most recent deal was a Later Stage VC with Thryv Therapeutics for . The deal was made on 03-Nov-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Thryv Therapeutics | 03-Nov-2026 | Later Stage VC | Drug Discovery | ||
| Specific Biologics | 02-Nov-2026 | Later Stage VC | Other Healthcare Technology Systems | ||
| Kainova Therapeutics | 10-Feb-2026 | Later Stage VC | Drug Discovery | ||
| Ocythera | 27-Jan-2026 | Seed Round | Biotechnology | ||
| Find Therapeutics | 09-Jan-2026 | Later Stage VC | Drug Discovery |
adMare Bioinnovations FAQs
-
When was adMare Bioinnovations founded?
adMare Bioinnovations was founded in 2019.
-
Where is adMare Bioinnovations headquartered?
adMare Bioinnovations is headquartered in Vancouver, Canada.
-
What is the size of adMare Bioinnovations?
adMare Bioinnovations has 68 total employees.
-
What industry is adMare Bioinnovations in?
adMare Bioinnovations’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is adMare Bioinnovations a private or public company?
adMare Bioinnovations is a Private company.
-
What is adMare Bioinnovations’s current revenue?
The current revenue for adMare Bioinnovations is .
-
Who are adMare Bioinnovations’s investors?
Government of Canada has invested in adMare Bioinnovations.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process